Since fructose 2,6-diphosphate is an allosteric activator of PFK-1 that can boost its catalytic activity considerably, PFKFB3 is necessary for the regulation of glycolysis and is an important therapeutic target for cancer. This evidence concerns the gene PFKM and cancer.